Smiths Medical launched its CAD D-Solis variable infusion profile system for homecare pain management in France, Germany, Switzerland and the Netherlands.

The CADD-Solis VIP system includes an infusion pump, medication safety software and medication cassette reservoirs that attach to the pump.

"Smart infusion devices have been widely adopted in hospitals as a means to help reduce the risk of medication delivery errors and improve efficiencies," Smiths’ VP of global product management Tommy Johns said in prepared remarks.  "Until now, however, smart infusion systems have not been designed for home patients or the professionals who care for them."

Sign up to get our free newsletters delivered straight to your inbox

The med-tech maker released its CADD hospital pain management system in 2008. The company adapted the new system to features important for homecare such as safety, mobility and reliability.

"The new CADD-Solis VIP system provides enhanced safety features and convenience for health care providers who want to provide optimal care for their infusion patients in either the home or hospital," said Johns

The CADD system is already available in the Middle East, the U.K., Canada and Australia.

Smiths is facing hard decisions as global governments cut spending. Smiths announced earlier this year that it would tighten its belt to the tune of about $62 million per year by 2014.

The St. Paul, Minn.-based medical device company said job cuts and plant closures are on the way for its detection unit, which includes drug-detection devices and airport X-ray scanners, but the company has yet to release numbers or locations.

"The economic outlook remains uncertain and continued pressures on government spending, which particularly impacted Smiths detection, medical and military communications division, are likely to continue to constrain revenue opportunities," according to CEO Philip Bowman.